Compare UFPT & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UFPT | PEB |
|---|---|---|
| Founded | 1963 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1993 | 2009 |
| Metric | UFPT | PEB |
|---|---|---|
| Price | $246.18 | $11.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 10 |
| Target Price | ★ $289.00 | $12.35 |
| AVG Volume (30 Days) | 156.2K | ★ 2.1M |
| Earning Date | 02-24-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 0.34% |
| EPS Growth | ★ 23.11 | N/A |
| EPS | ★ 8.61 | N/A |
| Revenue | $597,952,000.00 | ★ $1,464,126,000.00 |
| Revenue This Year | $21.91 | $2.11 |
| Revenue Next Year | $5.39 | N/A |
| P/E Ratio | $29.23 | ★ N/A |
| Revenue Growth | ★ 29.47 | 0.99 |
| 52 Week Low | $178.26 | $7.42 |
| 52 Week High | $289.57 | $14.21 |
| Indicator | UFPT | PEB |
|---|---|---|
| Relative Strength Index (RSI) | 47.07 | 42.61 |
| Support Level | $250.06 | $11.81 |
| Resistance Level | $272.60 | $12.79 |
| Average True Range (ATR) | 11.52 | 0.45 |
| MACD | -2.13 | -0.09 |
| Stochastic Oscillator | 8.39 | 5.17 |
UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.